A Study in Trained Taste Panel Healthy Adult Volunteers to Investigate the Palatability of Select Formulations of Cp-690,550 Oral Solution.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2010
At a glance
- Drugs Tofacitinib (Primary)
- Indications Crohn's disease; Plaque psoriasis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacodynamics
- Sponsors Pfizer
- 15 Jun 2010 Actual patient number (5) added as reported by ClinicalTrials.gov.
- 15 Jun 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 15 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.